Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 November 2022 | Story Anthony Mthembu | Photo Supplied
Lerato Pitso
Lerato Pitso, who will represent Lesotho in the Miss Supranational competition in 2023.

Lerato Pitso, a Bachelor of Social Sciences student at the University of the Free State (UFS), has been selected to represent her home country of Lesotho in the prestigious Miss Supranational competition, which will be held in Poland in 2023. “I’m still nervous about the fact that I have been selected to represent my country in this competition. However, the selection means that I have a lot of people who actually believe in me,” Pitso stated.

Miss Supranational

Miss Supranational is an internationally recognised beauty pageant overseen by the World Beauty Association.This is the third time that a UFS student has participated in this international competition. Earlier this year Boitumelo Sehlotho, a Bachelor of Accounting student at the UFS, who was also named the Face of Lesotho in 2019, represented her country at the Miss Supranational pageant 2022.  Thato Mosehle, a graduate from the Faculty of Health Sciences, was runner-up in the Miss Supranational pageant held in Poland in 2021.

Pitso perceives the pageant as a platform to encourage young women to do more to change the world. She was selected to represent Lesotho in the competition based on the contributions she made in and around her community.

Community Engagement

Pitso’s community engagement includes participation in a digital inclusion campaign in Lesotho. “The campaign intended to involve accountable ministries in addressing technological issues to empower students with technological skills to be competent for the global environment. Pitso was also involved in the Meal in a Jar initiative, which was run by the Office for International Affairs at the UFS. Through this initiative, high school learners in the Grassland community in Bloemfontein were taught to recycle materials, and to produce new products which they could then sell for profit. “The project aimed to spark an entrepreneurial mindset,” said Pitso. In addition, she has also worked with the SHE-HIVE Association, a non-governmental organisation based in Maseru, Lesotho, which offers counselling and legal assistance to those who have been affected by gender-based violence. As such, Pitso asserts that she is the best to represent her nation based on the work she has put in.

Preparing for the Miss Supranational stage

Pitso said getting ready for a competition of this magnitude is a huge undertaking. “Preparation for the big stage includes rigorous training in which one learns to walk in a certain manner, and a commitment to the gym in order to be physically fit for the competition.” She also asserts that taking care of her mental health is a priority before walking on that stage.

It is also important to note that the last two winners of the competition are from Africa, and this serves as motivation for Pitso. “The fact that people who come from a similar society to me could attain the prize makes me believe in myself. It means that it’s also possible for me to put in the work and excel in the competition,” she said.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept